EUVIMEDEUVIMED entdecken
Crossref

Therapeutic Potential of Curcumin in Diabetic Cardiomyopathy: Modulation of Pyroptosis Pathways

Fei Wang, Lehan Liu, Jiaxin Wang, Yizhu Zhou, Xiaochun Feng, Kun Liu iD

Cardiovascular Drugs and Therapy · 2026-02 · 40 (1) · 53-64

DOI: 10.1007/s10557-024-07644-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Drugs and Therapy, online erschienen am 09.01.2025. Verfasst von Fei Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, Affiliated Hospital of Nantong University, Nantong, 226000, Jiangsu, China. Hauptthemen laut MEDLINE: Pyroptosis, Diabetic Cardiomyopathies, Curcumin, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Science and Technology Project of Nantong City, Health Medical Collaborative Innovation Program of Guangzhou.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Cardiac inflammation is a basic pathological process of diabetic cardiomyopathy (DCM). Inflammatory response is closely related to pyroptosis, which is a recently identified programmed cell death type. Curcumin (CUR) is a polyphenol extracted from turmeric and has been reported to be crucial in alleviating pyroptosis in DCM. However, the exact mechanism by which CUR improves pyroptosis remains unclear. Therefore, we aimed to investigate the effect of CUR on pyroptosis in DCM and explore the potential mechanisms. METHODS: The molecular docking (MOD) analysis was performed using AutoDock Tools to evaluate the binding patterns and affinities between CUR and tripartite motif containing 21 (TRIM21), as well as between TRIM21 and gasdermin D (GSDMD). Subsequently, DCM models were established in Sprague-Dawley (SD) rats (in vivo) by administering streptozotocin (STZ) and feeding them a high-fat diet. In addition, H9C2 cells were cultured in a high glucose and palmitate environment to construct in vitro models of DCM. Rats or cells were treated by CUR directly. Subsequently, body weight (BW), heart weight (HW)/BW ratio, fasting blood glucose level, and lipid metabolism were measured. Pathological changes were analyzed using hematoxylin and eosin (H&E) and Masson staining. Small interfering RNA (si-RNA) was used to knockdown TRIM21 expression, and the pyroptosis protein expression and cellular activity were evaluated in different groups. RESULTS: MOD analysis revealed that CUR had a strong binding affinity with TRIM21, and TRIM21 showed a robust interaction with GSDMD. STZ-induced diabetic SD rats showed metabolic abnormalities, structural changes in the ventricle, and the expression of TRIM21 and pyroptosis markers, including nod-like receptor protein-3 (NLRP3), Caspase-1, and GSDMD, were upregulated. CUR reduced cardiac remodeling and improved cardiac function in vivo. CUR inhibited pyroptosis by regulating TRIM21 through in vivo and in vitro studies. CONCLUSION: CUR improves DCM by regulating TRIM21 expression to inhibit pyroptosis. Furthermore, this study provides novel approaches and experimental evidence for the research and treatment of DCM and presents new insights into its potential mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyroptosisDiabetic CardiomyopathiesCurcuminDiabetes Mellitus, ExperimentalMyocytes, CardiacAnimalsRats, Sprague-DawleyMalePhosphate-Binding ProteinsSignal TransductionMolecular Docking SimulationRatsIntracellular Signaling Peptides and ProteinsCell LineVentricular Function, LeftStreptozocinGasdermins

Stichwörter der Autor:innen

CurcuminDiabetic cardiomyopathyPyroptosisTRIM21

Substanzen

CurcuminPhosphate-Binding ProteinsGsdmd protein, ratIntracellular Signaling Peptides and ProteinsStreptozocinGasdermins

Autor:innen und Institutionen

  • Department of Cardiothoracic Surgery, Affiliated Hospital of Nantong University, Nantong, 226000, Jiangsu, China.
  • Medical School of Nantong University, Nantong, 226000, Jiangsu, China.
  • Department of Cardiothoracic Surgery, Affiliated Hospital of Nantong University, Nantong, 226000, Jiangsu, China. xiaochunfeng97@126.com.
  • Department of Cardiothoracic Surgery, Affiliated Hospital of Nantong University, Nantong, 226000, Jiangsu, China. lk717297@163.com.

ORCID-Profile: Kun Liu

Förderung

  • Science and Technology Project of Nantong City
  • Health Medical Collaborative Innovation Program of Guangzhou

Zitieren

APA

Wang, F., Liu, L., Wang, J., Zhou, Y., Feng, X., & Liu, K. (2026). Therapeutic Potential of Curcumin in Diabetic Cardiomyopathy: Modulation of Pyroptosis Pathways. Cardiovascular Drugs and Therapy, 40(1), 53-64. https://doi.org/10.1007/s10557-024-07644-3

Vancouver

Wang F, Liu L, Wang J, Zhou Y, Feng X, Liu K. Therapeutic Potential of Curcumin in Diabetic Cardiomyopathy: Modulation of Pyroptosis Pathways. Cardiovascular Drugs and Therapy. 2026;40(1):53-64. doi:10.1007/s10557-024-07644-3

BibTeX
@article{Wang2026,
  author = {Wang, Fei and Liu, Lehan and Wang, Jiaxin and Zhou, Yizhu and Feng, Xiaochun and Liu, Kun},
  title = {Therapeutic Potential of Curcumin in Diabetic Cardiomyopathy: Modulation of Pyroptosis Pathways},
  journal = {Cardiovascular Drugs and Therapy},
  year = {2026},
  volume = {40},
  number = {1},
  pages = {53--64},
  doi = {10.1007/s10557-024-07644-3}
}
Kostenlos starten →